MedPath

Effect of TCM cardiac rehabilitation program-liuzijue breathing method on cardiac function in patients with atrial fibrillation and chronic heart failure

Phase 1
Recruiting
Conditions
atrial fibrillation and chronic heart failure
Registration Number
ITMCTR2022000112
Lead Sponsor
Guang'anmen Hospital attached to China Academy of traditional Chinese Medical sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Age 30-80 years old, gender unlimited;
2. Meet the diagnostic criteria;
3. Good compliance;
4. Sign informed consent.

Exclusion Criteria

1. Exclude the abnormality of blood glucose, blood lipid and blood pressure caused by other primary diseases (chronic kidney disease, chronic liver disease and hypothyroidism);
2. Complicated with serious cardiovascular and cerebrovascular diseases, such as acute heart failure, severe hypertension, cerebral hemorrhage, etc;
3. Patients with severe liver dysfunction (ALT or ast reaching more than 3 times the upper limit of normal value), endocrine diseases, malignant tumors and autoimmune diseases;
4. Pregnant, pregnant or lactating women;
5. Allergic constitution and allergic to the components of this study;
6. Those who are participating in other clinical trials or have participated in other drug clinical trials for less than 1 month.
7. Patients with valvular atrial fibrillation.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
6-minute walking test;
Secondary Outcome Measures
NameTimeMethod
Echocardiographic parameters;Classification of cardiac function;Biochemical indicators;NT-proBNP;dynamic electrocardiogram;Symptoms of traditional Chinese medicine;Psychological scale score;
© Copyright 2025. All Rights Reserved by MedPath